Silver Pegasus Acquisition Corp.

The exhibit formalizes a consolidated reporting bloc for the Harraden Circle family of funds, which clarifies how beneficial ownership thresholds and future disclosure triggers will be calculated across the affiliated vehicles. While the filing holds no data on redemption mechanics or trust value, identifying a unified blockholder group is critical for tracking potential voting coalitions, takeover signaling, or sponsor alignment. Because the text explicitly cites Pyrophyte Acquisition Corp. II, investors should verify the correct target company before mapping this position to SPEG. Filing reference [0000950170-25-098194] was executed on July 24, 2025.

This filing fixes the trust deposit at $115,000,000 and sets the hard 18-month deadline for deal execution or liquidation, directly dictating the calendar for any redemption solicitations or extension proposals. The confirmation of zero merger talks and fully exercised underwriting options signals maximum capital accumulation with unchanged search timelines, requiring investors to factor in only interest accrual and administrative burn until a catalyst emerges. The fixed founder share count of 3,833,333 locks in a mathematical denominator for future pro forma calculations, while the disclosed derivative pricing parameters (17.00% combination probability, 8.16% volatility) provide explicit valuation assumptions for public rights and warrants absent active trading data. Although the company notes it has not independently verified the sponsor’s capacity to satisfy the indemnification promise, the contractual alignment between founder economics, working capital loan conversion rights, and the per-share trust floor outlines the precise incentive structure guiding the next 18 months of capital deployment.

This filing establishes the baseline trust value ($115M), the deadline (18 months), the sponsor's stake, the warrant structure, and the terms for future redemptions and business combination. Investors should note the 18-month deadline, the focus on semiconductors as stated in the press release, and the sponsor's locked-up founder shares. No target has been announced; the SPAC is now searching.

These structural terms dictate the precise liquidity exit parameters and timeline pressure applied to public capital, while the sponsor’s nominal founder share acquisition cost combined with automatic anti-dilution conversion math creates guaranteed baseline dilution to public shareholders independent of target selection outcomes.

Accelerating the S-1 effectiveness date compresses the statutory waiting period before public listing, which directly controls when subscriber funds enter the trust account, establishes the baseline net asset value against which future redemptions will be measured, and starts the 18- or 24-month business combination deadline.

This filing is the SPAC's IPO prospectus. It specifies the mechanics of redemption (up to 15% per shareholder without consent), the trust value ($10.00 per public share), the deadline (18 months), and the conduct of the sponsor and new non-managing sponsor investors. The non-managing sponsor investors (Harraden Circle) receive highly favorable terms: a low-cost exchange right for their warrants that creates a powerful incentive for them to vote for a business combination even if it destroys public shareholder value. The sponsor's nominal cost for founder shares (approx. $0.0075 each) means they profit enormously even if the combined company's stock price crashes. The filing establishes the structural conflicts of interest and potential dilution that investors in this SPAC will face.

For a SPAC in SEARCHING status, defining the warrant exchange trigger and confirming the $11.50 exercise price establishes equity conversion mechanics that directly affect post-combination share count and dilution. Disclosing additional founder shares issued to the Sponsor adjusts early-stage ownership and sponsor economic alignment ahead of any announced business combination.

The disclosed warrant exchange mechanism for non-managing sponsor investors creates a unique and potentially highly dilutive structure for public shareholders, especially if the post-business-combination stock price declines. The document also confirms the sponsor's nominal cost basis ($0.0075 per founder share), creating a misalignment of incentives where the sponsor could profit substantially even if public shareholders lose money. The trust is exactly $10.00 per unit ($100M for 10M units), and the deadline to complete a business combination is 18 months from the closing of the offering.

The compression to an 18-month operational clock directly tightens the calendar for any proposed redemption vote or extension proposal, accelerating sponsor decisions on whether to seek additional financing or pursue acquisition targets. The explicit permission for the sponsor to transfer or forfeit founder shares for no consideration fundamentally alters pre-deal governance expectations and could trigger liquidity events or control shifts unrelated to public shareholder votes.

For investors monitoring redemption deadlines and extension mechanics, the SEC’s confirmation of a compressed 18-month operational window shortens SPEG’s runway to consummate a merger before facing statutory redemption or liquidation triggers, increasing near-term cash preservation pressures.

This filing establishes the full contractual framework for the SPEG IPO. Material items for investors include: (1) The trust account of $10.00 per unit is confirmed. (2) The deadline to complete a business combination is 18 months from the closing of the offering (24 months in some textual references) or such earlier date as the board may approve, with the possibility of shareholder-approved extensions. (3) Public shareholders have redemption rights upon completion of a business combination, and no maximum redemption threshold is specified. (4) The sponsor, SilverLode Capital LLC, paid approximately $0.0075 per founder share, creating significant dilution potential for public shareholders. (5) The management team has prior SPAC experience — Cesar Johnston served as an advisor to KINS Technology Group (which had 99.3% public redemption at its business combination), and other directors have served on SPAC boards with varying outcomes. (6) Non-managing sponsor investors (Harraden Circle Investments affiliates) will indirectly hold economic interests in Class B.2 private placement warrants and 1,333,333 founder shares, giving them potentially different incentives than other public shareholders. (7) The B.2 warrants have unique features: non-redeemable, cannot be amended without consent, and holders can exchange them for shares based on a $0.60/Market Price formula when Market Price is below the exercise price, potentially causing significant dilution for public shareholders.

This correspondence confirms Silver Pegasus Acquisition Corp. remains in the pre-business combination registration review phase. No redemption calendar dates, trust value determinations, extension notices, merger progression milestones, or sponsor conduct allegations are reported. All directives originate exclusively from the SEC staff reviewing the January 21, 2025 filing. The review focuses on structural transparency rather than deal execution or investor protection triggers.

According to the Company’s submission via senior counsel Julia Aryeh, these revisions materially shift transparency around capital structure dilution and sponsor alignment prior to pricing. The Company states that non-managing sponsor investors originally signaled intent to purchase 100% of the offered units, but the Company withdrew those indication-of-interest figures from the prospectus because 'no expressions of interest have yet been communicated...

This S-1 is the first public disclosure of the SPAC's IPO terms, trust structure, redemption mechanics, and timeline. Investors can now evaluate the sponsor's track record, the dilution from founder shares, and the redemption rights. The 24-month deadline and the ability to redeem shares at $10.05 per share are key for investors assessing downside protection. The focus on technology and semiconductors provides a sector target. The filing also reveals the sponsor's low cost basis and the potential for conflicts of interest.

This comment letter dictates the structural and governance framework of the upcoming IPO, directly impacting how investors will assess redemption triggers, extension viability, and sponsor alignment. The mandatory disclosure of the 24-month deadline mechanics, extension limits, and sponsor penalties establishes the liquidation baseline and timeline pressure that drives redemption behavior.

Investors tracking redemption timelines should note the absence of a announced target and the hard 24-month expiration, meaning extension requests and associated cash outflows will depend entirely on future market conditions and board discretion. The registrant discloses a sponsor indemnity obligation that activates if third-party claims reduce trust balances below the lesser of $10.00 per public share or the actual trust amount, but management explicitly states it cannot verify whether the sponsor possesses sufficient funds outside the company to satisfy those claims.

What changed: A Schedule 13G/A amendment consisting solely of Exhibit A, a routine compliance exhibit known as a Joint Filing Agreement filed under SEC Rule 13d-1(k). This document is a procedural administrative instrument. The listed Harraden Circle investment vehicles, their general partners, and Frederick V. Fortmiller, Jr. formally agreed to submit the underlying Schedule 13G statement jointly on behalf of all named parties. The filing contains no amendments to beneficial ownership percentages, no updates to redemption calendars, no adjustments to trust account balances or distributions, no announcement or status update on a target search or business combination, and no disclosures regarding sponsor conduct, litigation, or corporate strategy. Per the signature block, Mr. Fortmiller, Jr. identifies himself as Managing Member for multiple Harraden Circle management entities, but these titles are internal organizational descriptions rather than operational commitments. Why it matters: For investors monitoring redemption deadlines, trust value, extension mechanisms, deal progression, or sponsor behavior, this filing delivers no operative information. It is a standard SEC-mandated wrapper required when multiple affiliated holders elect to consolidate their beneficial ownership reporting into a single submission. It confirms that Harraden Circle-affiliated entities maintain a registrable position in SPEG, but it does not alter the SPAC’s timeline, capital structure, acquisition pursuit, or shareholder rights.

What changed: SEC Schedule 13G beneficial ownership report. This filing identifies Bank of Montreal, BANK OF MONTREAL HOLDING INC., and BMO NESBITT BURNS INC. as reporting persons. Bearing on the requested mechanics, it discloses nothing regarding redemption deadlines, trust per-share value, extension mechanisms, merger deal progress, or sponsor conduct. Institutional 13G reports track equity position crossings and carry no regulatory mechanism to alter a SPAC’s redemption calendar or business combination timeline. Why it matters: Substantively, the provided excerpt contains zero claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. It also contains absolutely no numerical figures—no share totals, percentages, acquisition dates, or price points. As a routine compliance exhibit triggered by aggregate holding thresholds rather than corporate action, it provides no new operational intelligence for investors monitoring SPEG’s SEARCHING phase.

What changed: SEC Schedule 13G beneficial ownership report. This document identifies Glazer Capital, LLC and Paul J. Glazer as the reporting beneficial owners but provides no updated share quantities, ownership percentages, transaction dates, or amended purpose clauses. It reports no alterations to redemption deadlines, trust account mechanics, extension voting procedures, business combination milestone tracking, or sponsor governance actions. Per the required substance review, the filing makes no attributable claims concerning customer concentration, revenue figures, total addressable market projections, pivot strategies, proprietary technology stacks, partnership frameworks, civil or regulatory litigation, or executive leadership changes. Why it matters: Because the submission functions strictly as a baseline regulatory ownership disclosure devoid of transactional detail or strategic intent language, it does not trigger liquidity events, adjust trust distribution formulas, modify statutory liquidation calendars, or signal capital commitment escalations. The absence of percentage threshold crossings, pledge disclosures, or acquisition directives means existing redemption windows, warrant conversion paths, and sponsor fiduciary parameters remain operationally static. Portfolio managers tracking deal velocity should monitor subsequent Schedule 13G/A amendments, Regulation FD disclosures, or definitive business combination agreements that would formally update target qualification criteria and capital deployment timelines.

What changed: Exhibit A Joint Filing Agreement attached to an amended Schedule 13G beneficial ownership report. The filing states that Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong coordinated to submit a single amended Schedule 13G on behalf of all parties pursuant to Rule 13d-1(k), dated November 11, 2025. It attributes execution authority to Saul Ahn acting as general partner, general counsel, and attorney-in-fact under a June 10, 2019 power of attorney previously referenced in connection with Haymaker Acquisition Corp II. The excerpt discloses no updated share counts, cost bases, acquisition dates, or percentage ownership shifts relative to the prior statement. Why it matters: Nothing in this attachment bears on redemption deadlines, trust value, extensions, deal progress, or sponsor conduct. According to the document, it is purely a procedural compliance exhibit establishing filing protocol for consolidated equity reporting. Because the accompanying Schedule 13G/A statement page containing actual holdings, acquisition purposes, or potential plans is not included, the filing cannot inform investors about SPEG’s SEARCHING timeline, trust account composition, or merger negotiation status. It carries no material impact on SPAC mechanics or investment decisioning.

What changed: An 8-K current report and accompanying press release announcing the scheduled separation and distinct trading commencement of Silver Pegasus Acquisition Corp.’s Class A ordinary shares and public rights. The filing reports a purely mechanical listing change with no alteration to the specified investor protection mechanics: redemption deadlines, trust account values, extension provisions, deal progress, and sponsor conduct are entirely unaddressed and unchanged in this submission. Structurally, the Company’s press release announced that on or about September 8, 2025, holders of public units (trading as 'SPEGU') may elect to separate them into Class A ordinary shares ('SPEG') and rights ('SPEGR'). Each unit consists of one Class A ordinary share and one right entitling the holder to receive one-tenth of one Class A ordinary share upon consummation of an initial business combination. The release specifies that only whole rights will trade, with no fractional rights issued. Unseparated units continue trading under 'SPEGU'. Separation requires holders to direct their brokers to contact Continental Stock Transfer & Trust Company. These units originated from an underwritten offering completed on July 16, 2025, with Roth Capital Partners LLC acting as sole book-running manager. Why it matters: This submission marks a routine post-offering lifecycle transition that shifts liquidated exposure from bundled units to unbundled shares and derivative-like rights prior to any target announcement. It does not dictate shareholder voting windows, cash-out triggers, or mechanical adjustments to the trust pool. Regarding corporate fundamentals, the press release characterizes the registrant as a Cayman Islands exempted blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination across 'any industry, sector or geographic location,' while expressly noting a strategic focus on 'semiconductors and systems solutions.' Chief Executive Officer Cesar Johnston is identified as the primary contact and executed the signature block. The filing cross-references a registration statement/prospectus declared effective by the SEC on July 14, 2025.

What changed: 10-Q quarterly report filed by Silver Pegasus Acquisition Corp., a blank check company that is still searching for a business combination target. The 10-Q covers the period before the SPAC's IPO. On July 16, 2025, after the quarter ended, the SPAC consummated its IPO of 11,500,000 units at $10.00 per unit (including the full over-allotment), generating $115,000,000 in gross proceeds. Simultaneously, it sold 3,250,000 Private Placement Warrants at $1.00 per warrant for $3,250,000. $115,000,000 was placed in the trust account ($10.00 per public share). The 18-month deadline to complete a business combination runs from July 16, 2025 (i.e., January 16, 2027). The sponsor's promissory note of $179,649 was fully paid off with IPO proceeds. The 500,000 founder shares subject to forfeiture became unconditional. Why it matters: This is the definitive filing establishing the trust pool ($115,000,000 at $10.00 per share), the 18-month deadline, the warrant structure and the sponsor economics. Investors can now track the trust against this baseline. The company has no identified target yet, so the clock is now running.

What changed: A Joint Filing Agreement (Exhibit A) accompanying a Schedule 13G beneficial ownership report, explicitly referencing the Shares of Pyrophyte Acquisition Corp. II. Per the filing, Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; and Frederick V. Fortmiller, Jr. have agreed to file jointly under Rule 13d-1(k), with Fortmiller designated as the Managing Member signatory across all vehicles. The document contains no adjustments to SPEG’s redemption deadlines, trust account balance or valuation, extension proposals, merger progress, or sponsor conduct disclosures. It explicitly names Pyrophyte Acquisition Corp. II rather than SPEG. Why it matters: The exhibit formalizes a consolidated reporting bloc for the Harraden Circle family of funds, which clarifies how beneficial ownership thresholds and future disclosure triggers will be calculated across the affiliated vehicles. While the filing holds no data on redemption mechanics or trust value, identifying a unified blockholder group is critical for tracking potential voting coalitions, takeover signaling, or sponsor alignment. Because the text explicitly cites Pyrophyte Acquisition Corp. II, investors should verify the correct target company before mapping this position to SPEG. Filing reference [0000950170-25-098194] was executed on July 24, 2025.

What changed: A Form 8-K Current Report and accompanying audited balance sheet with comprehensive notes, disclosing the consummation of an initial public offering and concurrent private placement. As confirmed in the report signed by President and Chief Executive Officer Cesar Johnston, the company consummated its IPO on July 16, 2025, selling 11,500,000 units at $10.00 per unit for $115,000,000 in gross proceeds, with the full exercise of a 1,500,000-unit over-allotment option. The sponsor purchased 2,000,000 private warrants and the underwriter representative purchased 1,250,000 private warrants at $1.00 each, generating $3,250,000. Per the audited balance sheet and notes, $115,000,000 was deposited into a trust account as of July 16, 2025. The filing establishes an 18-month completion window from the IPO closing date before mandatory public share redemption occurs if no business combination is achieved. Management states that as of July 16, 2025, the company had not selected a target and had not engaged in any substantive discussions regarding an initial business combination. Founder equity stands at 3,833,333 Class B ordinary shares after the sponsor surrendered 1,916,667 shares upon full over-allotment exercise; these shares convert one-for-one to Class A ordinary shares at business combination, carry waived redemption rights, and remain locked until six months post-combination or a $12.00 closing price trigger. Sponsor conduct commitments include waiving founder share liquidation rights if a deal fails, indemnifying the trust against third-party claims that reduce trust assets below the lesser of $10.00 per public share or the actual per-share trust amount, and paying the sponsor $10,000 monthly for administrative services starting July 14, 2025. Working capital loans up to $1,500,000 remain available and convertible to Class B.1 warrants at $1.00 per warrant. Audited notes disclose that public rights are classified as a derivative liability valued at $1,930,850 and private warrants as a derivative liability valued at $774,475, with management utilizing an estimated probability of business combination of 17.00% and 8.16% volatility in their Monte Carlo and Black-Scholes-Merton valuation models. Why it matters: This filing fixes the trust deposit at $115,000,000 and sets the hard 18-month deadline for deal execution or liquidation, directly dictating the calendar for any redemption solicitations or extension proposals. The confirmation of zero merger talks and fully exercised underwriting options signals maximum capital accumulation with unchanged search timelines, requiring investors to factor in only interest accrual and administrative burn until a catalyst emerges. The fixed founder share count of 3,833,333 locks in a mathematical denominator for future pro forma calculations, while the disclosed derivative pricing parameters (17.00% combination probability, 8.16% volatility) provide explicit valuation assumptions for public rights and warrants absent active trading data. Although the company notes it has not independently verified the sponsor’s capacity to satisfy the indemnification promise, the contractual alignment between founder economics, working capital loan conversion rights, and the per-share trust floor outlines the precise incentive structure guiding the next 18 months of capital deployment.

What changed: Schedule 13G Joint Filing Agreement (Exhibit A to a Beneficial Ownership Report). This excerpt is exclusively the Joint Filing Agreement executing Rule 13d-1(k) coordination among eight Harraden Circle investment vehicles and principal Frederick V. Fortmiller, Jr. It confirms they are treating their combined SPEG positions as a single reporting unit. No shifts in redemption deadlines, trust account mechanics, extension proposals, or target acquisition milestones are referenced, as the operative Sections 2 through 6 of the Schedule 13G—which would disclose exact share counts, acquisition dates, sources of funds, stated transaction purposes, and underlying securities—are omitted from this text. Why it matters: Establishes a co-managed, concentrated investor cohort under common control via Managing Member Frederick V. Fortmiller, Jr., which clarifies potential voting bloc alignment and collective influence over SPEG’s future shareholder votes on business combinations or charter amendments. Because the document contains only the signatory authorization page, it does not alter redemption calendars, modify assumed per-share trust distributions, or indicate sponsor conduct deviations; the Harraden Circle entities have not yet disclosed purchase prices, aggregate stakes, or whether they intend to participate in or oppose upcoming redemption windows or extension votes.

What changed: A Joint Filing Agreement (Exhibit A) attached to a Schedule 13G beneficial ownership report. According to the agreement dated July 21, 2025, there are no amendments, notices, or operational updates pertaining to redemption deadlines, trust account balances, extension clauses, target acquisition progress, or sponsor governance. The text merely records the mutual consent of Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong to satisfy their Section 13(d) reporting obligations through a single consolidated submission. Why it matters: As executed by the named entities, the exhibit consolidates their collective equity disclosure for SPEG under Rule 13d-1(k), with Saul Ahn signing in his capacity as authorized representative for the two Linden affiliates and as attorney-in-fact for Siu Min Wong pursuant to a standalone Power of Attorney dated June 10, 2019 (cross-referenced from a prior Haymaker Acquisition Corp II holding). For investors tracking the SPAC’s corporate timeline, this filing locks in the recognized reporting structure for the underlying stakeholder group, provides zero insight into cash trust distributions or conversion windows, and carries no implication for pending business combinations or sponsor activity. It is a routine compliance exhibit that clarifies ownership aggregation without shifting redemption clocks or capital deployment schedules.